08:30
|
Antigen versus non-antigen specific intervention: The "pros" and "cons"
|
10 |
09:00
|
Current ongoing trials and the issue of multiple intervention strategies in newly diagnosed patients (P. Pozzilli and I. Raz)
|
11 |
09:30
|
Current ongoing trials and the issue of multiple intervention strategies in high risk subjects
|
12 |
10:00
|
The rate of progression of ß-cell destruction from diagnosis of type 1 diabetes on
|
13 |